(Q38073601)

28 August 2017

1 reference

title

Circulating tumor cells as therapy-related biomarkers in cancer patients (English)

1 reference

28 August 2017

0 references

Tobias M Gorges

1

1 reference

PubMed ID

23314304

28 August 2017

Klaus Pantel

series ordinal

2

1 reference

28 August 2017

12 January 2013

1 reference

Cancer Immunology, Immunotherapy

28 August 2017

1 reference

28 August 2017

62

1 reference

28 August 2017

5

1 reference

28 August 2017

931-939

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-012-1387-1

28 August 2017

0 references

cites work

Tumor self-seeding by circulating cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells and circulating tumor DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Review: Biological relevance of disseminated tumor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells and bone marrow micrometastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Plasticity of disseminating cancer cells in patients with epithelial malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Circulating tumor cells as emerging tumor biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Quantitative high-resolution genomic analysis of single cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Treatment of HER2-positive breast cancer: current status and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1387-1

10.1007/S00262-012-1387-1

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

23314304

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23314304